Clinical-stage biotechnology innovating next-generation molecular therapies
Pharmaceutical

A science-driven biotech focused on developing novel therapeutic candidates targeting serious human diseases, especially in oncology and infectious disease. Using a proprietary platform of structurally-designed ribose-based molecules, this company advances small-molecule compounds that work by modulating key biological pathways to potentially stop viral replication, activate the immune system, and overcome treatment resistance. Its lead programs include orally-administered agents progressing through clinical trials with the aim of delivering safer, more effective treatments for cancer and severe infections.